This interview dives into Curisosis' live cell imaging systems and how they improve reproducibility in cell-based assays.
Invivoscribe®, a global leader in precision diagnostics and measurable residual disease (MRD) testing, today announced ...
This Clinical Chemistry and Laboratory Medicine review examines a central challenge in precision medicine: whether medical ...
The expanded panel includes 93 new microorganism-drug combinations, bringing the total panel size to 215, and in conformity with all the most current FDA breakpoints.